+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05380414

Profiling Program for Patients with Advanced or Metastatic Pancreatic Cancer Using Molecular Screening Before First Treatment

Led by Centre Leon Berard · Updated on 2026-03-31

750

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a molecular screening program for patients with advanced or metastatic pancreatic cancer before they start their first line of treatment. The goal is to better select patients for personalized medicine using targeted drugs andor combinations involving chemotherapy. This study is a prospective, single-center program led by Centre Leon Berard, focusing on identifying actionable genetic alterations that may guide treatment decisions. Participants will provide tumor samples, including archival formalin-fixed paraffin-embedded FFPE tissue and optional new biopsies, as well as blood samples for molecular screening. The study does not involve randomization or blinding and primarily assesses the number of patients with actionable genetic alterations. It aims to support tailored therapies based on molecular profiling and track the initiation of targeted treatments during the study. During the study, researchers will monitor outcomes such as progression-free survival, overall survival, best overall response, and duration of response over up to 12 months. They will also record the time from consent to the start of the next therapy line. The study includes assessments of patient health status, life expectancy, and performance score. Participation lasts up to five years, during which molecular and clinical data will be collected and analyzed to inform future personalized treatment strategies.

CONDITIONS

Brief Title

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

Research Team

P

Philippe CASSIER, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here